title: Protective actions of L-carnitine and acetyl-L-carnitine on the neurotoxicity evoked by mitochondrial uncoupling or inhibitors.
abstract: The mechanism for the pathological increase in cell death in various disease states e.g. HIV immunodefficiency or even ageing or Alzheimer's disease, occurs by complex and as yet undefined mechanism(s) related to immunological, virological or biochemical disturbances (i.e. energy depletion, oxidative stress, increased protein degradation). We have studied mitochondrial uncoupling or inhibitor toxicity on neurones at the cellular level and at the mitochondrial level using rhodamine (Rh123) and 10-nonylacridine orange (NAO) fluorescence with confocal microscopy. Blockade of the mitochondrial chain complexes at various points was studied. The possible protective effects of the compound L-carnitine, which plays a central role in mitochondrial function, was tested in this form of neurotoxicity. It appears that L-carnitine and its acetylated form, acetyl-L-carnitine, can attenuate the cell damage, as assessed by lactate dehydrogenase (LDH) release, evoked by the uncoupler, p-(trifluoromethoxy)phenylhdyrazone (FCCP), or by the inhibitors, 3-nitropropionic acid (3-NPA) or rotenone. Further, the FCCP-induced inhibition of Rh123 uptake was antagonized by the preincubation of cells with L-carnitine. Since such neurotoxic mechanisms may be operating in the various pathological forms of myotoxicity and neurotoxicity, these observations suggest potential for a therapeutic approach.
authors: Sigma-Tau, Pomezia, Rome.
authors: M A
authors: MA
authors: Virmani
authors: R
authors: R
authors: Biselli
authors: A
authors: A
authors: Spadoni
authors: S
authors: S
authors: Rossi
authors: N
authors: N
authors: Corsico
authors: M
authors: M
authors: Calvani
authors: A
authors: A
authors: Fattorossi
authors: C
authors: C
authors: De Simone
authors: E
authors: E
authors: Arrigoni-Martelli
mesh_terms: D000108:Acetylcarnitine / Q000494:pharmacology*; D000818:Animals; D002259:Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone / Q000633:toxicity; D002331:Carnitine / Q000494:pharmacology*; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000187:drug effects / Q000201:enzymology; D005333:Fetus; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D018613:Microscopy, Confocal; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism; D009474:Neurons / Q000187:drug effects / Q000201:enzymology; D018696:Neuroprotective Agents / Q000494:pharmacology*; D009574:Nitro Compounds; D011422:Propionates / Q000633:toxicity; D051381:Rats; D012235:Rhodamines; D012402:Rotenone / Q000633:toxicity
chemical_list: D018696:Neuroprotective Agents; D009574:Nitro Compounds; D011422:Propionates; D012235:Rhodamines; D012402:Rotenone; D002259:Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; D000108:Acetylcarnitine; D007770:L-Lactate Dehydrogenase; C015392:3-nitropropionic acid; D002331:Carnitine